Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome.

Our results highlight a link between MetS and hyperhomocysteinemia and a direct effect of Hcy on atherogenic process during MetS. Early correction of folic acid levels may contribute to prevent cardiovascular complications in MetS patients.